Home › NDC Lookup › Ingredients › Azithromycin › 70771-1423-02
Azithromycin 200 mg/5mL Powder, For Suspension — NDC 70771-1423-02 package photo

Azithromycin 200 mg/5mL Powder, For Suspension

by Zydus Lifesciences Limited · 1 BOTTLE in 1 CARTON (70771-1423-2) / 15 mL in 1 BOTTLE
NDC 70771-1423-02
🏷️ FDA NDC (as labeled) 70771-1423-2 billing pads the package segment with a zero
Rx only Generic On market Non-controlled
🗂️ Data synced Jul 24, 2026 · sources: openFDA · FDA label (DailyMed) · FDA Orange & Purple Book · First Databank · CMS NADAC, ASP, Medicare & Medicaid · RxNorm
📋 All sources & update times →

This page is curated, coded, and maintained by

Compiled from public FDA, CMS, DailyMed, NADAC, and related drug data sources. Editorial policy

🆔 Identity & classification

FDA NDC (as labeled) 70771-1423-2
Product NDC 70771-1423
11-digit billing NDC 70771142302
RxCUI 141963, 308459
UNII 5FD1131I7S
Application # ANDA211147
SPL Set ID 0b63649d-558c-4250-90ee-af6e1e5c6d2c
Established class (EPC) Macrolide Antimicrobial
Chemical class Macrolides
DEA schedule Non-controlled
Marketing category ANDA
Marketing status On market
FDA listing status Listed (active directory)
Marketing start 2018-08-06
Route ORAL
Dosage form POWDER, FOR SUSPENSION
Substance AZITHROMYCIN DIHYDRATE
TE code (Orange Book) AB · RLD · RS
Why two NDCs? The FDA registers this code as 70771-1423-2 — a 5-4-1 layout, and that's what's printed on the package and shown on DailyMed. For insurance claims, every NDC is standardized to a uniform 11-digit 5-4-2 format by adding a zero to the package segment → 70771-1423-02. Same drug, same package — only the format differs.
Where does this data come from?
Identifiers from the FDA openFDA NDC Directory and Structured Product Labeling; RxCUI from RxNorm (NLM); GPI from Medi-Span; GCN / HIC / AHFS / legend from First Databank.

🏷️ RxNorm drug class

This medicine belongs to the Macrolide Antimicrobial class.

Pharmacologic class Macrolide Antimicrobial
Drug family (ATC) Macrolides, Antibiotics
Where does this data come from?
Therapeutic classes from RxNorm RxClass (U.S. National Library of Medicine) — Established Pharmacologic Class (FDA), ATC drug family (WHO) and mechanism of action, matched by this product’s RxCUI.

🏭 Manufacturer & labeler

LabelerZydus Lifesciences Limited
Application holderZYDUS LIFESCIENCES GLOBAL FZE
FDA applicationANDA211147 (ANDA)
Labeler code70771
First marketedAug 2018
Product typeHuman Prescription Drug
Portfolio717 products on file
The labeler markets the product; the application holder owns the FDA approval. They’re often the same company but can differ (e.g. a repackager or an authorized generic). A mailing address / phone appears here when the manufacturer includes it in the product’s FDA label (not all do).
Where does this data come from?
Labeler, application holder and registered establishment from the FDA openFDA NDC Directory and Drugs@FDA; address/contact from the product’s FDA label.

🩺 Clinical

📖 What it is MedlinePlus · NLM

Azithromycin is used to treat infections caused by bacteria. It is also used to treat and prevent disseminated Mycobacterium avium complex (MAC) infection [a type of lung infection that affects people with a suppressed immune system). Azithromycin is in a class of medications called macrolide antibiotics. It works by stopping the growth of bacteria. Antibiotics such as azithromycin will not work for colds, flu, or other viral infections. Using antibiotics when they are not needed increases your risk of getting an infection later that resists antibiotic treatment.

Read the full MedlinePlus article ↗
📗 Our plain-language guide HelloPharmacist
📖 Read our full Azithromycin guide →
7
Nutrient depletion considerations

Azithromycin may be associated with lower levels of 7 nutrients — worth a chat with your pharmacist, not a cause for alarm.

🧪 Full Azithromycin nutrient depletion report →
An association is not a deficiency. Educational only — don't start or stop anything without professional guidance.
Where does this data come from?
Plain-language summary from MedlinePlus (U.S. National Library of Medicine); supplement & herbal interactions and nutrient depletion data from the Natural Medicines database; our full guide is HelloPharmacist editorial content.

💊 What it looks like

Color White
FlavorBanana
One label can cover several strengths, so colors may be combined — always confirm a loose pill against the dispensed prescription label or a pharmacist.
Where does this data come from?
Physical description (imprint, shape, color, scoring, coating) from this product’s FDA Structured Product Labeling (SPL), mirrored from DailyMed / openFDA.

🧪 Inactive Ingredients / Excipients

Inactive ingredients, also called excipients, are components of the drug product other than the active ingredient. They may include fillers, dyes, coatings, preservatives, flavors, or other formulation ingredients.

💡 Tap an ingredient (hover on desktop) to see what it is and why it’s used.

  • UNII WZB9127XOA
    A synthetic red dye used to color medications and make them easier to identify. It serves as a colorant in tablets, capsules, and liquid formulations.
  • UNII UKE75GEA7F
    Hydroxypropyl cellulose is a plant-based polymer used as a binder and thickener. It helps hold tablet ingredients together, controls how fast the medicine dissolves, and improves the texture of liquid formulations.
  • UNII SX01TZO3QZ
    A mineral salt made from sodium and phosphate. It acts as a buffer to maintain the medicine's pH level and can help bind ingredients together in solid dosage forms.
  • UNII C151H8M554
    A natural sugar derived from sugar cane or sugar beets. It's used as a sweetener, filler, and binder to improve taste, add bulk, and help hold tablet or capsule ingredients together.
  • UNII TTV12P4NEE
    Xanthan gum is a thickening and stabilizing ingredient made from fermented corn or other sugars. It's added to medicines to improve texture, prevent separation of liquids and solids, and help the product stay consistent.

5 inactive ingredients listed in the exact product block matched to this NDC.

Where does this data come from?
Data sourced from official FDA Structured Product Labeling (SPL) via DailyMed — ingredient classCode="IACT" elements from the exact product block matched by this NDC. Label-section narrative from DailyMed / the openFDA label index is shown separately when available.

Inactive ingredient FAQ

Are inactive ingredients the same for every manufacturer?
No. Inactive ingredients can differ by manufacturer, dosage form, strength, and package / product version.
Why might an inactive ingredient be missing?
Some SPLs do not provide a complete structured inactive-ingredient list, and older or unusual labels may only include the information in narrative text.
Can inactive ingredients matter?
Yes. They can matter for allergies, intolerances, dyes, gluten / lactose concerns, preservatives, and formulation differences — but confirm with a pharmacist or the manufacturer when it’s clinically important.

💲 Pricing

A drug doesn't have one price. Each row is a different public payment system, and none is what you'd pay at the counter — that depends on your insurance. The ⓘ on each row explains what it measures.

Price systemPer mLPer package
Retail pharmacies payNADAC · weekly Not in the retail survey — common for institutional, discontinued, or low-volume packs.
Medicaid paysCMS SDUD · 12 mo No recent Medicaid claims on file for this NDC — rare and low-volume NDCs are suppressed in the public data.
Medicare drug plans payPart D · Q2 2026 $0.3238 $4.86 / 15 ml
Where does this data come from?
NADAC (National Average Drug Acquisition Cost) is the CMS weekly pharmacy-acquisition-cost survey — what pharmacies pay. ASP (Average Sales Price) is the CMS Medicare Part B drug-payment file, published quarterly. Medicaid pays is computed by us from CMS State Drug Utilization Data (total reimbursed ÷ units, trailing 12 months) — gross of rebates and inclusive of dispensing fees, so it reflects what Medicaid paid, not an acquisition cost. Medicare drug plans pay is the median negotiated point-of-sale unit cost across plans listing this NDC in the CMS quarterly Prescription Drug Plan pricing files, before rebates. The VA pays is the federal contract price (FSS, and the statutory Big 4 ceiling where listed) from the VA National Acquisition Center pharmaceutical price file. All are free public government data; each measures a different payer, so the figures are not directly comparable.

🔁 Therapeutic equivalents

ProductLabelerPackNADAC/unitTEStatusPrice vs. this
Azithromycin 200 mg/5mL 24658-0708-34 PURACAP 30 ml $0.210 AB Availability likely —
Azithromycin 200 mg/5mL 42806-0151-34 Epic 30 ml $0.210 AB Availability likely —
Azithromycin 200 mg/5mL 62135-0705-43 Chartwell 30 ml $0.210 AB Availability likely —
Azithromycin 200 mg/5mL 70710-1460-02 Zydus 1 bottle $0.210 AB Availability likely —
azithromycin dihydrate 200 mg/5mL 70436-0222-36 Slate 1 bottle $0.219 AB Availability likely —
Azithromycin 200 mg/5mL 24658-0707-33 PURACAP 22.5 ml $0.231 AB Availability likely —
Azithromycin 200 mg/5mL 42806-0150-33 Epic 22.5 ml $0.231 AB Availability likely —
Azithromycin 200 mg/5mL 70710-1459-02 Zydus 1 bottle $0.231 AB Availability likely —
azithromycin dihydrate 200 mg/5mL 70436-0228-49 Slate 1 bottle $0.238 AB Availability likely —
Azithromycin 200 mg/5mL 00093-2026-23 Teva 15 ml $0.298 AB Availability likely —
Azithromycin 200 mg/5mL 11788-0129-13 AiPing 1 bottle $0.298 AB Availability likely —
Azithromycin 200 mg/5mL 24658-0706-32 PURACAP 15 ml $0.298 AB Availability likely —
Azithromycin 200 mg/5mL 42806-0149-32 Epic 15 ml $0.298 AB Availability likely —
Azithromycin 200 mg/5mL 59651-0008-15 Aurobindo 1 bottle $0.298 AB Availability likely —
Azithromycin 200 mg/5mL 70710-1458-02 Zydus 1 bottle $0.298 AB Availability likely —
azithromycin dihydrate 200 mg/5mL 70436-0221-34 Slate 1 bottle $0.325 AB Availability likely —
Zithromax 200 mg/5mL 00069-3120-19 Pfizer 1 bottle — AB FDA listed —
Zithromax 200 mg/5mL 00069-3130-19 Pfizer 1 bottle — AB FDA listed —
Zithromax 200 mg/5mL 00069-3140-19 Pfizer 1 bottle — AB FDA listed —
Azithromycin 200 mg/5mL 50090-4458-00 A-S 1 bottle — AB FDA listed —
Azithromycin 200 mg/5mL 50090-6226-00 A-S 22.5 ml — AB FDA listed —
Azithromycin 200 mg/5mL 50090-6267-00 A-S 1 bottle — AB FDA listed —
Azithromycin 200 mg/5mL 50090-6296-00 A-S 15 ml — AB FDA listed —
Azithromycin 200 mg/5mL 55695-0003-00 STATE 30 ml — AB FDA listed —
Azithromycin 200 mg/5mL 63187-0093-15 Proficient 15 ml — AB FDA listed —
Azithromycin 200 mg/5mL 67296-2141-01 Redpharm 1 bottle — AB FDA listed —
Azithromycin 200 mg/5mL 68071-3897-02 NuCare 22.5 ml — AB FDA listed —
Azithromycin 200 mg/5mL 68071-4773-05 NuCare 15 ml — AB FDA listed —
Azithromycin 200 mg/5mL 68071-4779-03 NuCare 30 ml — AB FDA listed —
Azithromycin 200 mg/5mL 68071-4795-03 NuCare 30 ml — AB FDA listed —
Azithromycin 200 mg/5mL 68788-7549-03 Preferred 30 ml — AB FDA listed —
Azithromycin 200 mg/5mL 68788-8246-03 Preferred 1 bottle — AB FDA listed —
Azithromycin 200 mg/5mLthis 70771-1423-02 Zydus 1 bottle — AB FDA listed —
Azithromycin 200 mg/5mL 70771-1424-02 Zydus 1 bottle — AB FDA listed —
Azithromycin 200 mg/5mL 70771-1425-02 Zydus 1 bottle — AB FDA listed —
Azithromycin 200 mg/5mL 71205-0216-30 Proficient 1 bottle — AB FDA listed —
Azithromycin 200 mg/5mL 71205-0253-30 Proficient 30 ml — AB FDA listed —
Azithromycin 200 mg/5mL 71205-0566-15 Proficient 15 ml — AB FDA listed —
Azithromycin 200 mg/5mL 72189-0314-22 DirectRx 22.5 ml — AB FDA listed —
Azithromycin 200 mg/5mL 72673-0081-60 Zhejiang 1 bottle — AB FDA listed —
Azithromycin 200 mg/5mL 72673-0082-90 Zhejiang 1 bottle — AB FDA listed —
Azithromycin 200 mg/5mL 72673-0083-12 Zhejiang 1 bottle — AB FDA listed —
About this product: this is a generic version of the medicine. FDA equivalence ratings are shown when available, and other versions are listed above, least expensive first.
Where does this data come from?
Equivalents are other NDCs of the same ingredient, form and route from the openFDA NDC Directory, ranked least-expensive-first by NADAC. Therapeutic-equivalence (AB) ratings come from the FDA Orange Book; biologics use the FDA Purple Book for biosimilar & interchangeable status.

⏳ Availability & generic status

🏛️
2018
On the market since
Aug 2018
📍
2026
Currently FDA-listed
8 years listed
🔓
·
Generic on the market
this product is a generic
✅This is a generic drug

This product is an FDA-approved generic. Other versions of the same drug are listed under Therapeutic equivalents, least expensive first.

Where does this data come from?
Patents and exclusivity from the FDA Orange Book (small-molecule drugs), refreshed from public FDA data. Generic launch timing is an estimate, not a guarantee.

📊 Medicare Part D spend CMS · PART D · 2026 (Q1)

Medicare Part D (outpatient prescription) spending for Azithromycin — the program that covers self-administered drugs. 19 manufacturers.
⚠️ Drug-level data: CMS publishes Part D spending by drug, not by NDC — these figures combine every manufacturer, strength and package size sold under the name Azithromycin. That’s a different level of aggregation than the Medicaid card above, which is specific to this exact 11-digit NDC (pack size included), so the two aren’t directly comparable.
Period
Total Part D spend
$13.72M
Claims incl. refills
2.4M
Beneficiaries
2.2M
Spend / beneficiary
$6.32
Spend / claim
$5.61
Trend by period
💵 About the dollar figures: spending is what Part D plans paid before confidential manufacturer rebates, so the program’s real net cost is lower. A blank patient count means fewer than 11 people — CMS hides counts that small to protect privacy. Source: CMS Medicare Quarterly Part D Spending by Drug (data.cms.gov), updated quarterly.

🔬 Reported adverse events (FAERS)

Read carefully: FAERS reports are voluntary and unverified. Counts are not incidence, do not establish causation, are subject to reporting bias, and cannot be used to compare one drug to another. Shown for signal context only. Reports for Azithromycin — the ingredient across all brands.

Top reported reactions

Dyspnoea4,651
Nausea3,461
Pain3,279
Pneumonia3,225
Cough3,120
Drug Hypersensitivity2,991
Diarrhoea2,951

Reporter sex

59,712 reports
Male · 38%
Female · 61%
Unknown · 1%

Serious outcomes

Death5,260
Reports over time (by year) — tap or hover for the count & year
2019 2021 2023 2026 6,750 0
Most recent year is provisional (FAERS lags ~3 months).
Where does this data come from?
Adverse-event reports from the FDA Adverse Event Reporting System (FAERS) via openFDA. FAERS reports are voluntary and unverified — counts are not incidence and don’t establish causation.

📦 Packaging — all sizes for this product

Package NDCDescription Marketing startStatus
70771-1423-02 You're viewing this 1 BOTTLE in 1 CARTON (70771-1423-2) / 15 mL in 1 BOTTLE 2018-08-06 Active

🧭 About this NDC listing & data coverage

Finished prescription product
What data is (and isn’t) available for this NDC — tap to expand
NDC identity (package / product / labeler codes) ✓ Available
Labeler ✓ Available
Product & package description ✓ Available
Marketing category & status ✓ Available
Active ingredient / dosage form / route ✓ Available
FDA label (SPL via DailyMed) ✓ Available
Package photos ✓ Available
Inactive ingredients (structured) ✓ Available
NADAC pharmacy acquisition price (CMS) — Not published for this NDC CMS publishes NADAC only for NDCs reported in its retail-pharmacy survey.
Orange Book / therapeutic-equivalence data ✓ Available
HCPCS J-code billing crosswalk — Not published for this NDC Most self-administered / retail products have no J-code — that is normal.
Medicaid utilization (CMS SDUD) — Not published for this NDC CMS reports utilization only for NDCs with Medicaid claims above its privacy threshold.
“Not published” reflects what the public FDA / CMS / NLM sources provide for this exact package code — it is a property of the data feeds, not a judgment about the product.

Questions about this listing

Why is there no price listed?
The pricing shown on our NDC pages comes from CMS NADAC, a voluntary survey of retail community pharmacy invoices. CMS does not publish a NADAC for every NDC — packages outside the retail survey (institutional and hospital products, bulk packages, discontinued items, and many OTC items) may never receive one. A missing price reflects the survey's scope, not this product's actual cost, and does not mean the product is free or unavailable.
Is the NDC printed on the package the same as the 11-digit billing NDC?
Yes, they identify this exact package in different formats. The FDA registers it as 70771-1423-2, which is what is printed on the packaging and shown on DailyMed. Insurance claims use a fixed 11-digit 5-4-2 format, so the short segment is padded with a leading zero: 70771-1423-02, written without dashes as 70771142302. The Identity section at the top of this page lists every form of this code.
What do the three segments of this NDC mean?
In 70771-1423-02, the first segment (70771) is the labeler code FDA assigned to Zydus Lifesciences Limited; the middle segment (1423) identifies this specific product — its ingredient, strength, and dosage form; and the last segment (02) identifies this exact package size and type. Together they name one specific package of one specific product.
Is this package still being marketed?
Yes, per the latest FDA NDC Directory data on this page: this package is listed as actively marketed, with no marketing end date reported by Zydus Lifesciences Limited. Listing status can change — the directory data on this page refreshes weekly.
Who lists this product with the FDA?
Zydus Lifesciences Limited is the labeler of record for this NDC — the company under whose FDA-assigned code the package is listed. The labeler may be the manufacturer itself or a distributor marketing the product under its own code.
Do I need a prescription for this product?
This NDC is listed with FDA as a prescription product, so it is dispensed under a prescriber's order. Your pharmacist can tell you whether any over-the-counter forms of the same medication exist.
This page identifies an FDA-listed package (the NDC) and reports public regulatory and pricing data about the listing. It is reference information, not a medical recommendation — talk to your pharmacist or prescriber about your own medication.
Where does this data come from?
Listing facts (marketing category, packager status, marketing dates) from the FDA openFDA NDC Directory; label availability from DailyMed; pricing coverage from CMS NADAC; equivalence scope from the FDA Orange Book.

📄 Full prescribing information FDA SPL

The complete FDA label for this product — the official prescribing information, verbatim, section by section. Jump with a chip, search within the label, or expand everything.
📄 FDA label
📄 FDA label 9 words ▾

No readable label sections were found for this product.

Source: FDA Structured Product Labeling, mirrored from DailyMed / openFDA. Prefer the government’s original formatting? View this label on DailyMed ↗
← 70771-1422-01 · Zydus 70771-1424-02 · Zydus →
For educational and professional reference only — not medical advice. Pricing reflects published NADAC and CMS ASP (free public data) and may differ from your acquisition cost; always verify before billing or dispensing.